Understanding how transthyretin proteins misfold and cause diseases

Molecular mechanisms of transthyretin amyloidosis

NIH-funded research Scripps Research Institute, the · NIH-11050903

This study is looking at how certain proteins misbehave in transthyretin amyloidosis, which can cause serious health problems, to understand how they clump together in the body and how things like fluid flow might affect this process, with the hope of finding new ways to treat these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11050903 on NIH RePORTER

What this research studies

This research investigates the molecular mechanisms behind transthyretin amyloidosis, a condition where proteins misfold and aggregate, leading to serious health issues like neurodegenerative diseases and heart problems. The study focuses on how these proteins behave under normal physiological conditions, particularly how fluid flow affects their aggregation. By using advanced biophysical tools, researchers aim to uncover the fundamental processes that lead to the formation of harmful protein deposits in the body. This knowledge could pave the way for new therapeutic strategies to combat these diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with transthyretin amyloidosis or those at risk due to genetic factors.

Not a fit: Patients with amyloidosis caused by other proteins or unrelated conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from transthyretin amyloidosis and related conditions.

How similar studies have performed: Previous research has shown promising results in understanding protein misfolding and aggregation, making this approach both relevant and potentially impactful.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions amyloid disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.